Assessment of the global and national market for lipid modifying agents: retrospective and innovation

Lipid-lowering therapy is one of the most important aspects in the treatment of patients with cardiovascular disease, which is still the leading cause of death in the adult population. Over the past 10 years, fundamentally new lipid-lowering drugs have appeared such as alipogene tiparvovec, mipomers...

Full description

Bibliographic Details
Main Authors: A. V. Lokhmacheva, S. G. Fominykh, L. V. Trubina, I. E. Sikhvardt
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Siberian Branch Publishing House 2023-08-01
Series:Сибирский научный медицинский журнал
Subjects:
Online Access:https://sibmed.elpub.ru/jour/article/view/1154